Ohio’s Medical Marijuana Control Program (MMCP) was passed with bi-partisan support and signed by Governor Kasich in 2016, making Ohio the 25th state in the nation to pass a comprehensive medical cannabis program.
In order to participate in the Ohio Medical Marijuana Control (MMCP) program, patients must have at least one of the following 21 qualifying medical conditions:
• Amyotrophic lateral sclerosis (ALS)
• Alzheimer’s disease
• Chronic traumatic encephalopathy (CTE)
• Crohn’s disease
• Epilepsy or another seizure disorder
• Hepatitis C
• Inflammatory bowel disease
• Multiple sclerosis
• Pain that is either chronic and severe or intractable
• Parkinson’s disease
• Positive status for HIV
• Post-traumatic stress disorder (PTSD)
• Sickle cell anemia
• Spinal cord disease or injury
• Tourette’s syndrome
• Traumatic brain injury
• Ulcerative colitis
The MMCP allows patients to purchase medical cannabis in the form of oils, tinctures, plant material, edibles, and patches. While the purchase of flower products for use with certain approved herbal vaporizers is permitted, any smoking or combustion of medical cannabis is not.
Patients are limited to purchasing a 45-day supply of medicine within each 45-day period of their recommendation. In addition, the THC content of products has been capped to limit potential complications and side effects. Plant material may not have THC content greater than 35% and extracts may not have THC content greater than 70%.
To participate in the program, patients must be registered with the Ohio Board of Pharmacy by a state-certified recommending physician.